treatment of heart transplant patients with a powerful immune suppressing drug appears to sharply increase their risk of a lethal form of blood cell cancer a study concludes researchers found that 11 of patients at one hospital who were treated this way quickly developed lymphoma and most of those people died the treatment is called okt3 an antibody that attacks a variety of white blood cells that play a key role in making the body reject the transplanted organ the new study shows that even if okt3 prevents rejection and this is in doubt the benefit comes at a high price of cancer risk